RecruitingPhase 2NCT04677816

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Studying Disorders of vitamin D metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Wake Forest University Health Sciences
Principal Investigator
Emily H Douglas, MD, MD
Wake Forest University Health Sciences
Intervention
Standard of Care Neoadjuvant Chemotherapy (NAC)(drug)
Enrollment
50 target
Eligibility
18 years · All sexes
Timeline
20212026

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04677816 on ClinicalTrials.gov

Other trials for Disorders of vitamin D metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorders of vitamin D metabolism

← Back to all trials